Economist – Probuy-mart
Economist
0
0

The above is the title of a useful manual of Kenney and Keast (2024). I summarize some key points below. Provide an overview of pharmacy contracts ...

0
0

See my previous posts on negotiating IRA prices in drug selection (Part 1) and sending manufacturer data (Part 2). Today we will talk about the ...

0
0

CMS launched Guidance on Negotiating IRA Prices last week. Below are some highlights on how medications will be selected. What medications are eligible ...

0
0

To account for differences in disease burden among the patient population of Medicare Advantage (MA) plans, risk adjustment based on the patient's disease ...

0
0

In July 2018, the FDA published the Biosimilars Action Plan (BAP), which outlined the FDA's approach to expanding access ...

0
0

Progression-free survival (PFS) is a surrogate endpoint defined as follows (by ChatGPT): Essentially, PFS refers to the period of time during a ...

0
0

Medical debt in the United States is a major problem. While more than 90% of people have health insurance, many people ...

0
0

Samsung Bioepis has a Biosimilars Market Report for Q2 2024. Some key highlights: As of April 2024, the FDA approved ...

0
0

For patients with serious illnesses, timely access to effective medications is paramount. The European Medicines Agency (EMA) was created in part to help ...

0
0

The Digital Therapeutics Alliance defines a digital therapeutics (DTx) as “evidence-based therapeutic interventions ...

Probuy-mart
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart